Medical devices, healthcare technology and the business of care
510(k) clearance · K261630

GI Windows Flexagon Plus OTOLoc System

GI Windows Surgical · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONK261630

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 2026-10-28 for the GI Windows Flexagon Plus OTOLoc System, submitted by GI Windows Surgical of Canton, Massachusetts. The submission is K261630, a traditional 510(k) received on 05/18/2026 and handled under product code SAH within the General and Plastic Surgery specialty and review panel. The public record lists the device classification name as Magnetic Compression Anastomosis System.

SESE means the submission was cleared as substantially equivalent to a legally marketed predicate device; it is not a PMA approval. The record shows no third-party review, no combination product designation and no authorized predetermined change control plan. The reviewed documents do not identify the predicate device, the specific components or changes assessed, or the basis for the equivalence finding, so those details remain unknown from this source.

The page was last updated 11/02/2026. No clinical performance data, indications for use or labeling content appear in the available excerpts, and none should be inferred from the clearance decision alone.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 28, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261630
Regulatory pathway
510(k) premarket notification
Product code
SAH
Decision code
SESE
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Magnetic Compression Anastomosis System.

Product code
SAH
FDA device class
2

FDA decision timeline

  1. K261630 received

    Application receipt date recorded by FDA.

  2. K261630 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code SAH

Product / regulatory recordCompanyPathwayDecision dateSource
Gt Metabolic Solutions, Inc.510(k) clearanceSep 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

GI Windows Surgical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Canton, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records